NEWSpublisher 2007 :: AngloChinese Investments
SEARCH NEWS
date from:
date to:
company:
search for string:
NEWS SECTIONS
COMPANY GROUPS
TOP NEWS
» 23/07/2009 [Company watch]
China Aoxing Pharmaceutical Corp. Receives Renewal of GMP Certification for Capsule Dosage Form of Pharmaceutical Products
» 15/03/2010 [Industry news]
Recordati S.p.A And Lee Pharmaceutical Announce Partnership For Zanidip(R) In China
» 26/10/2009 [Finance]
China Growth to Remain Fast in Fourth Quarter, Official Says
» 17/08/2009 [Industry news]
Chindex Posts Profit on Product Sales, Health Services
» 07/05/2010 [Industry news]
Hong Kong: Recall of all products manufactured by Quality Pharmaceutical Lab Ltd
COMPANY NEWS back to previous page show list
»02/02/2010 [Industry news]
SPG digests recent acquisitions but still hungry for more, will keep name

Shanghai Pharmaceutical Group (SPG), which is planning for six months of company integration efforts after its recent acquisitions, will retain the same company name going forward.

 
Shanghai Pharmaceutical Group (SPG), which is planning for six months of company integration efforts after its recent acquisitions, will retain the same company name going forward. All medical assets post-integration will be injected into Shanghai Pharmaceutical (SHA: 600849) for trading, according to ChinaTimes February 2, An analyst stated that Shanghai Pharmaceutical Group plans to create a new retail model by expanding its distribution network across the country, and cooperating with the mega-retailer Bailian Group as well as with other local distributors. Xinsheng Ma, chairman of the board of Bailian Group, also stated that the company\'s subsidiary, Shanghai No.1 Pharmacy, may be integrated into SPG, but the timeline is not clear. In the past year, SPG has received approval to take over Shanghai Pharmaceutical (SHA: 600849), Shanghai Industrial Pharmaceutical Investment (SIPI) (SHA: 600607), and Shanghai ZhongXi Pharmaceutical (SHA: 600842). It was reported January 13 that SPG signed an agreement of strategic cooperation with Bailian Group, a major shareholder of Shanghai No.1 Pharmacy

AngloChinese Investments ltd.
Home | Company news | TOP 50 | Events | About us
C&F Bright Solutions ltd.